Industry · mRNA, cell and gene therapy
For mRNA, cell and gene therapy
Lipid nanoparticles, characterisation and formulation with fewer screening rounds.
What we solve for you
Bioanalytics: peptides, proteins, oligos, metal binding
Our small-molecule workflows cannot cleanly evaluate peptide and oligo identity, modifications and metal binding.
See solutionLNP formulation
Lipid screening and LNP optimisation cost us months in the lab.
See solutionBiologics: developability and sequence design
Our candidates fail late on viscosity, aggregation or immunogenicity.
See solution
Evaluated for you, done yourself or learned
Evaluated for you
You send the data, we deliver the reviewed report. From EUR 1,490 net, typically 5 working days after complete data.
See reportPilot project
One question on your data, with a success criterion agreed in writing beforehand. From EUR 1,490 net, fully creditable.
See pilot projectDo it yourself
One seat for you, cancel monthly. EUR 0, 250 or 750 per user and month, net.
Try it freeLearn
Your team learns it on its own data, online or in Leipzig. EUR 490 to 1,990 per person, in-house EUR 3,500 to 9,900, net.
See learning
Next step
Which case is on your desk right now?
30 minutes on Microsoft Teams with the CovaSyn team. If it is not a fit, we will say so.